Gainers
• Aerpio Pharmaceuticals, Inc. ARPO shares moved upwards by 74.85% to $1.09 during Wednesday's pre-market session.
• Edap TMS, Inc. EDAP stock moved upwards by 27.85% to $2.80. The most recent rating by B. Riley, on Apr 15, is at Buy, with a price target of $6.
• Genocea Biosciences, Inc. GNCA shares rose 21.85% to $3.29.
• Progyny, Inc. PGNY shares moved upwards by 16.64% to $23.90. The most recent rating by Citigroup, on Mar 10, is at Buy, with a price target of $29.
• Alcon, Inc. ALC stock rose 11.79% to $59.55. The most recent rating by Wells Fargo, on Apr 9, is at Overweight, with a price target of $58.
• Organovo Holdings, Inc. ONVO stock rose 11.47% to $0.82.
• Adamis Pharmaceuticals, Inc. ADMP shares increased by 11.15% to $0.58.
• Capricor Therapeutics, Inc. CAPR shares increased by 11.14% to $8.78.
• Forward Pharma, Inc. FWP stock moved upwards by 10.10% to $8.50.
• Veru, Inc. VERU shares moved upwards by 9.35% to $3.86.
Losers
• KemPharm, Inc. KMPH shares declined 13.70% to $0.25 during Wednesday's pre-market session.
• Phio Pharmaceuticals, Inc. PHIO shares declined 10.53% to $2.21.
• Adaptive Biotechnologies, Inc. ADPT stock fell 9.62% to $34.40.
• Baudax Bio, Inc. BXRX shares decreased by 9.43% to $3.17. The most recent rating by Oppenheimer, on May 11, is at Outperform, with a price target of $14.
• bluebird bio, Inc. BLUE stock decreased by 6.79% to $53. The most recent rating by RBC Capital, on May 13, is at Outperform, with a price target of $100.
• Outlook Therapeutics, Inc. OTLK stock decreased by 6.10% to $0.77.
• Acer Therapeutics, Inc. ACER stock fell 5.87% to $3.53.
• Helius Medical, Inc. HSDT shares fell 5.69% to $0.61.
• Eiger BioPharmaceuticals, Inc. EIGR shares decreased by 5% to $11.41. The most recent rating by Wedbush, on Apr 3, is at Outperform, with a price target of $33.
• ObsEva, Inc. OBSV shares decreased by 4.76% to $3.40. The most recent rating by HC Wainwright & Co., on Mar 23, is at Buy, with a price target of $36.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.